Breast Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting on the Use of Oral SERDs and Agents Targeting the PI3K/AKT/mTOR Pathway
Featuring perspectives from Dr Sara A Hurvitz, Dr Erica Mayer, Dr Joyce O’Shaughnessy, Dr Sara M Tolaney and Dr Nicholas Turner, moderated by Dr Tolaney, including the following topics:
Introduction (0:00)
Current and Future Roles of Agents Targeting the PI3K/AKT/mTOR Pathway and Oral Selective Es…
Breast Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting on the Use of Oral SERDs and Agents Targeting the PI3K/AKT/mTOR Pathway
Featuring perspectives from Dr Sara A Hurvitz, Dr Erica Mayer, Dr Joyce O'Shaughnessy, Dr Sara M Tolaney and Dr Nicholas Turner, moderated by Dr Tolaney, including the following topics:
Introduction (0:00)
Current and Future Roles of Agents Targeting the PI3K/AKT/mTOR Pathway and Oral Selective…
Breast Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting on the Use of Oral SERDs and Agents Targeting the PI3K/AKT/mTOR Pathway
Featuring perspectives from Dr Sara A Hurvitz, Dr Erica Mayer, Dr Joyce O’Shaughnessy, Dr Sara M Tolaney and Dr Nicholas Turner, moderated by Dr Tolaney, including the following topics:
Introduction (0:00)
Current and Future Roles of Agents Targeting the PI3K/AKT/mTOR Pathway and Oral Selective Es…
HR 3 | Radio-Telethon Day 1 continues!
This hour: Maddie Squire, 26, Breast Cancer Survivor, with Erica Mayer, MD, Dir., Patient & Family Programs, The Jimmy Fund Clinic, Dana-Farber Cancer Institute; Lisa Scherber, Dir., Patient & Family Programs, The Jimmy Fund Clinic, Dana-Farber Cancer Institute; Peter Chow, 68, Stage IV Lung Cancer…
Maddie Squire, 26, Breast Cancer Survivor, with Erica Mayer, MD, Dir., Patient & Family Programs, The Jimmy Fund Clinic, Dana-Farber Cancer Institute
Maddie Squire, 26, Breast Cancer Survivor, with Erica Mayer, MD, Dir., Patient & Family Programs, The Jimmy Fund Clinic, Dana-Farber Cancer Institute, both join Jones & Keefe live from the 2026 WEEI/NESN Jimmy Fund Radio-Telethon!
Conference Highlights: New Breast Cancer Research from ASCO 2026
In this Breast Cancer Breakthroughs series, Harold Burstein, MD, PhD, speaks with breast cancer experts from Dana-Farber about new research presented at the 2026 ASCO Annual Meeting.
Topics include advances in early and metastatic breast cancer, new treatment approaches, clinical trial results, foo…
Oral SERDs for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances
Featuring perspectives from Dr Aditya Bardia and Dr Erica Mayer, including the following topics:
Introduction: How Selective Estrogen Receptor Degraders (SERDs) Work (0:00)
Second-Line Treatment for Metastatic Breast Cancer (16:01)
First-Line Therapy for Metastatic Disease (33:19)
Adjuvant Th…
Camizestrant + CDK 46i FDA Approval in Hormone Receptor Positive Breast Cancer SERENA-6
Welcome to another episode of the Oncology Brothers! In this episode, we dived into the recent FDA approval of camizestrant for the treatment of hormone receptor–positive metastatic breast cancer, based on the SERENA-6 trial.
We welcomed Dr. Erica Mayer, a breast medical oncologist from the Dana-F…
ASCO 2026 Highlights Panel Discussion
In this episode of Breast Cancer Insights, Harold Burstein, MD, PhD, speaks with Dana-Farber breast cancer experts Sara Tolaney, MD, MPH; Nancy Lin, MD; Erica Mayer, MD, MPH; and Jennifer Ligibel, MD, about important breast cancer research presented at the 2026 ASCO Annual Meeting.
The experts disc…
Episode 65: The evERA Breast Cancer Trial
Recently published in NEJM, this trial made significant noise as it may be the stepping stone to changing how we manage a subset of breast cancer.Dr. Erica Mayer, the first author and lead investigator, joined Healthcare Unfiltered EXPRESS to share all you must know about the trial and potential ne…
PODCASTIDE OTSINGUMOOTOR
Saate kasutada meie veebisaiti3,826,122taskuhäälingusaadete ja196,016,103osade otsimiseks inimeste, kohtade või teemade järgi.
I have no special talent. I am only passionately curious, and
I listen to podcasts.
‐ Albert "Llamacorn" Einstein
MUUDA
Aitäh, et aitad hoida podcastide andmebaasi ajakohasena.
